Effectiveness of 2-dose Vaccination with MRNA COVID-19 Vaccines Against COVID-19–associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
Supporting Files
Public Domain
-
-
-
Series:
File Language:
English
Details
-
Description:What is already known about this topic? Studies suggest that immunocompromised persons who receive COVID-19 vaccination might not develop high neutralizing antibody titers or be as protected against severe COVID-19 outcomes as are immunocompetent persons.
What is added by this report? Effectiveness of mRNA vaccination against laboratory-confirmed COVID-19–associated hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%). Vaccine effectiveness varied considerably among immunocompromised patient subgroups.
What are the implications for public health practice? Immunocompromised persons benefit from COVID-19 mRNA vaccination but are less protected from severe COVID-19 outcomes than are immunocompetent persons. Immunocompromised persons receiving mRNA COVID-19 vaccines should receive 3 doses and a booster, consistent with CDC recommendations, practice nonpharmaceutical interventions, and, if infected, be monitored closely and considered early for proven therapies that can prevent severe outcomes.
Suggested citation for this article: Embi PJ, Levy ME, Naleway AL, et al. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021. MMWR Morb Mortal Wkly Rep. ePub: 2 November 2021.
mm7044e3.htm?s_cid=mm7044e3_x
mm7044e3-H.pdf -
Subjects:
-
ISSN:0149-2195 (print) ; 1545-861X (digital)
-
Document Type:
-
Place as Subject:
-
Pages in Document:7 pdf pages
-
Volume:70
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:56722e8577609f492bbd5ea6c00bab450c9436f0a8dfed41ac920e44f9599f85e227bcd0b4f721ea154d234571d8606d193a3a46688a032286ab576fce153de8
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Morbidity and Mortality Weekly Report (MMWR)